References
- WHO. Regional Office for Europe/European Observatory on Health Systems and Policies. Policy brief. Screening in Europe. 2006; [cited 2019 Jan 3]. Available from: http://www.euro.who.int/en/about-us/partners/observatory/publications/policy-briefs-and-summaries/screening-in-europe.
- Brodersen J, Schwartz LM, Woloshin S. Overdiagnosis: how cancer screening can turn indolent pathology into illness. APMIS. 2014;122:683–9.
- Hogberg C, Karling P, Rutegard J, et al. Immunochemical faecal occult blood tests in primary care and the risk of delay in the diagnosis of colorectal cancer. Scand J Prim Health Care. 2013;31:209–14.
- Marshall KG. Prevention. How much harm? How much benefit? 3. Physical, psychological and social harm. CMAJ. 1996;155:169–76.
- Holme O, Bretthauer M, Fretheim A, et al. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev. 2013;9:CD009259.
- Dansk Tarmkraeftscreeningsdatabase. Årsrapport 2017 - Nationale praevalens screeningsrunde [Danish colorectal cancer screening database. Annual report 2017 - National prevalence screening round], [cited 2019 Jan 3]. Available from: https://www.sundhed.dk/sundhedsfaglig/kvalitet/kliniske-kvalitetsdatabaser/screening/dansk-tarmkraeftscreeningsdatabase/
- Brodersen J, Thorsen H. Consequences of Screening in Breast Cancer (COS-BC): development of a questionnaire. Scand J Prim Health Care. 2008;26:251–6.
- Solbjor M, Forsmo S, Skolbekken JA, et al. Psychosocial consequences among women with false-positive results after mammography screening in Norway. Scand J Prim Health Care. 2018;36:380–9.
- Mant D, Fitzpatrick R, Hogg A, et al. Experiences of patients with false positive results from colorectal cancer screening. Br J Gen Pract. 1990;40:423–5.
- Miles A, Atkin WS, Kralj-Hans I, et al. The psychological impact of being offered surveillance colonoscopy following attendance at colorectal screening using flexible sigmoidoscopy. J Med Screen. 2009;16:124–30.
- Wardle J, Williamson S, Sutton S, et al. Psychological impact of colorectal cancer screening. Health Psychol. 2003;22:54–9.
- Parker MA, Robinson MH, Scholefield JH, et al. Psychiatric morbidity and screening for colorectal cancer. J Med Screen. 2002;9:7–10.
- Brasso K, Ladelund S, Frederiksen BL, et al. Psychological distress following fecal occult blood test in colorectal cancer screening–a population-based study. Scand J Gastroenterol. 2010;45:1211–6.
- Kapidzic A, Korfage IJ, van Dam L, et al. Quality of life in participants of a CRC screening program. Br J Cancer. 2012;107:1295–301.
- DeFrank JT, Barclay C, Sheridan S, et al. The psychological harms of screening: the evidence we have versus the evidence we need. J Gen Intern Med. 2015;30:242–8.
- Halkier B. Fokusgrupper [Focus groups]. 2. ed. Frederiksberg (Denmark): Samfundslitteratur; 2008.
- Malterud K. Systematic text condensation: a strategy for qualitative analysis. Scand J Public Health. 2012;40:795–805.
- Hestbech MS, Siersma V, Dirksen A, Pedersen JH, Brodersen J. Participation bias in a randomised trial of screening for lung cancer. Lung Cancer. 2011;73:325–31.
- Welch HG, Schwartz L, Woloshin S. Overdiagnosed: making people sick in the pursuit of health. 1st ed. Boston (MA): Beacon Press; 2012.
- Yang C, Sriranjan V, Abou-Setta AM, et al. Anxiety associated with colonoscopy and flexible sigmoidoscopy: a systematic review. Am J Gastroenterol. 2018;113(12):1810–8.
- Crombie I, Orbell S, Johnston G, et al. Women's experiences at cervical screening. Scott Med J. 1995;40:81–2.
- Hofmann B. Ethical issues with colorectal cancer screening - a systematic review. J Eval Clin Pract. 2017;23:631–41.
- Brodersen J, Schwartz LM, Heneghan C, et al. Overdiagnosis: what it is and what it isn't. BMJ Evid Based Med. 2018;23:1–3.
- Griffiths F, Bendelow G, Green E, et al. Screening for breast cancer: medicalization, visualization and the embodied experience. Health. 2010;14:653–68.
- Griffiths F, Green E, Bendelow G. Health professionals, their medical interventions and uncertainty: a study focusing on women at midlife. Soc Sci Med. 2006;62:1078–90.
- Gram IT, Lund E, Slenker SE. Quality of life following a false positive mammogram. Br J Cancer. 1990;62:1018–22.
- Rasmussen JF, Siersma V, Pedersen JH, et al. Healthcare costs in the Danish randomised controlled lung cancer CT-screening trial: a registry study. Lung Cancer. 2014;83:347–55.
- Lafata JE, Simpkins J, Lamerato L, et al. The economic impact of false-positive cancer screens. Cancer Epidemiol Biomarkers Prev. 2004;13:2126–32.
- Barton MB, Moore S, Polk S, et al. Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits. J Gen Intern Med. 2001;16:150–6.
- Getz L, Brodersen J. Informed participation in cancer screening: the facts are changing, and GPs are going to feel it. Scand J Prim Health Care. 2010;28:1–3.